BrainInsight
K220815Hyperfine, Inc. · cleared 2022-07-19 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.4)
“BrainInsight is a fully automated MR imaging post-processing medical software that provides image alignment, whole brain segmentation, ventricle segmentation, and midline shift measurements of brain structures from a set of MR images from patients ages 18 years or older.”
source quote (p.4)
“The BrainInsight processing architecture includes a proprietary automated internal pipeline based on machine learning tools. The modified BrainInsight described in this submission includes changes to the machine learning models to allow for the processing Al-reconstructed low-field MR images.”
Validation studies (1)
Retrospective clinical
sample size not stated
standards: IEC 62304:2006
Reported performance (6 observations)
source quote (p.7)
“Left Ventricle 84”
source quote (p.7)
“Right Ventricle 82”
source quote (p.7)
“Whole Brain 95”
source quote (p.7)
“Left Ventricle 81”
source quote (p.7)
“Right Ventricle 79”
source quote (p.7)
“Whole Brain 96”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
- re_clearance
The FDA AI/ML device list shows a newer 510(k) K223268 (decision 2022-12-16) from Hyperfine, Inc. for a matching device line ("BrainInsight") — a new clearance for the same line is a change event.
first seen 2026-07-08 · k_number:K223268
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).